MerckMillipore100 99• New SMCxPRO™ technology offers high speed, high sensitivity for single molecule detection

• Meets customer demand for biomarker and novel target discovery and  detection


Darmstadt, Germany, April 3, 2017 – Merck, a leading science and technology company, today announced the launch of its newest high-sensitivity detection platform, SMCxPRO™ technology, at the American Association for Cancer Research Annual Meeting in Washington, D.C.


The complete Merck News Release can be downloaded at the following link:$File/MerckIntroducesProteinDetection040317.pdf


Additional picture(s):$File/SMCxPRO.jpg